Chemokine receptor binding heterocyclic compounds

• Main Authors: TREVOR R. WILSON, MARIA ROSARIAFLURI, DONINIQUE SCHOLS, BERN ATSMA, CURTIS HARWIG, GARY BRIDGER, AL KALLER, YUANXI ZHOU, CHRISTOPHER DENNIS SMITH, RENATO SKERLJ, SIQIAO NAN, ERNEST J. MCEACHERN, DAVID BOGUCKI, JASON CRAWFORD
• Format: Patent
• Language: English
• Published: 21.05.2004
• Edition: 7
• Subjects: CHEMISTRY; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; HETEROCYCLIC COMPOUNDS; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; METALLURGY; ORGANIC CHEMISTRY; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS; TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE; TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE

Compounds which modulate chemokine receptor activities are disclosed. These compounds are preferably tertiary amines comprising tetrahydroquinoline and benzimidazole.